Study Purpose:
The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complications of ALS (such as severity of involuntary movements) may interfere with the use of cyberlink.Study Status:
Not recruiting
Disease:
Amyotrophic Lateral Sclerosis , Neurodegenerative Disease , Motor Neuron Disease
Study Type:
Observational
Type of Intervention:
N/A
Intervention Name:
N/A
Placebo:
N/A
Phase:
N/A
Study Chair(s)/Principal Investigator(s):
Terry Heiman-Patterson, MD, MDA/ALS Center of Hope
Clinicaltrials.gov ID:
Neals Affiliated?
No
Coordinating Center Contact Information
MDA/ALS Center of Hope
Philadelphia, Pennsylvania, 19104 United States
Full Study Summary:
The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complications of ALS (such as severity of involuntary movements) may interfere with the use of cyberlink.
Study Sponsor:
Drexel University College of Medicine
Estimated Enrollment:
1
Estimated Study Start Date:
11 / 30 / 2004
Estimated Study Completion Date:
04 / 01 / 2009
Posting Last Modified Date:
03 / 05 / 2013
Date Study Added to neals.org:
07 / 18 / 2008
Minimum Age:
18 Years
Maximum Age:
75 Years
Can participants use Riluzole?
Yes
Inclusion Criteria:- Those aged 18-75 diagnosed with probable or definite ALS.
Exclusion Criteria:
- Those with decision impairment will not be considered.
MDA/ALS Center of Hope
Philadelphia, Pennsylvania
19104
United States